Invasive Basal Cell Carcinoma of the Head and Neck (Basalioma Terebrans)

ABSTRACT

In a retrospective study, initial diagnosis and method of treatment were evaluated in 118 patients with invasive basal cell carcinoma (formerly basalioma terebrans) of the head and neck. In 97 of the total 118 patients, radical surgery with resection of important organs had to be performed, and the follow-up results of 107 patients were recorded. In 44 (41%) of the latter 107 cases, recurrences were observed despite radical tumor excision, and only 63 (59%) patients were free of tumor. In 20 patients a second recurrence and in 12 patients a third recurrence was found. The recurrence rate amounted to only 1.9% in a comparative study group of 6932 patients with “simple” basal cell carcinoma. The findings reveal that healing without recurrence was achieved in only half of the patients with invasive basal cell carcinoma (basalioma terebrans). In cases in which bony structures had been invaded by the tumor, the recurrence rate was 71.4%. Despite the hypothesis of primary incurability of invasive basal cell carcinoma, it is pointed out that radical surgery may still improve a patient's quality of life. Although definite healing seems impossible, surgery may contribute to an acceptable quality of life for several years.

KEYWORDS

Basal cell carcinoma - invasive basal cell carcinoma - basalioma terebrans - facial defects - recurrence of basal cell carcinoma - facial prostheses - amputation of parts of the face - exenteration of orbit - amputation of the nose - resection of the midface

REFERENCES

• 1 Darier 1896, zitiert nach Melczer N. Präcancerosen und primäre Krebse der Haut. Budapest, Hungary: Akademiai Kiado; 1961
• 2 Jacob W, Scheida D, Wingent F, eds. Tumor-Histologie-Schlüssel ICD-O-DA. Berlin, Germany: Springer; 1978
• 3 Crowson A N. Basal cell carcinoma: biology, morphology and clinical implications.  Mod Pathol. 2006;  19 (Suppl 2) S127-S147
• 4 Drepper H, Tilkorn H. Basalioma terebrans des Gesichtes. In: Pfeifer G, Schwenzer N, eds. Fortschr Kiefer-Gesichtschir. 1982. 27: 7-11
• 5 Holubar K. Basaliome. In: Kortin G W, ed. Dermatologie in Praxis und Klinik, Bd IV. Stuttgart, Germany: Thieme; 1981: 41.21-41.40
• 6 Olbrisch R R, Mühlbauer W. Das verwilderte Basaliom.  Plast Chir. 1981;  5 108-116
• 7 Salfeld K. Die klinische Vielfalt der Basaliome. In: Eichmann F, Schnyder U W, eds. Das Basaliom. Der häufigste Tumor der Haut. Berlin and Heidelberg, Germany: Springer; 1981: 1-15
• 8 Tilkorn H, Tilkorn M, Drepper H, Schwipper V. Das Basalzellkarzinom – Besondere Aspekte bei der Behandlung. In: Macher E, Kolde G, Bröcker E B, eds. Tumoren der Haut, Jahrbuch der Dermatologie. Biermann Zülpich; 1994: 209-222
• 9 Schubert J, Müller A. [Basaliomas with invasion of bone: problems and prognosis].  Mund Kiefer Gesichtschir. 1997;  1 44-46
• 10 Tritsch H. Das Wachstumsverhalten der Basaliome. In: Eichmann F, Schnyder U W, eds. Das Basaliom. Der häufigste Tumor der Haut. Berlin and Heidelberg, Germany: Springer; 1981: 55-62
• 11 Breuninger H, Sebastian G, Kortmann R D, Schwipper V, Werner J, Garbe C. Deutsche Leitlinie: Basalzellkarzinom. In: Garbe C, ed. Interdisziplinäre Leitlinien zur Diagnostik und Behandlung von Hautumoren. Stuttgart, Germany: Thieme; 2005: 1-11
• 12 Schubert J, Basaliomas S J. Mund Kiefer Gesichtschir. 2000;  4 (Suppl 1) 169-176
• 13 Burg G, Hirsch R D, Konz B, Braun-Falco O. Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma.  J Dermatol Surg. 1975;  1 21-24
• 14 Härle F. Atlas der Hauttumoren des Gesichts. München and Wien, Germany: Hanser; 1993
• 15 Irmisch A C. Therapie und Prognose des Basalioma terebrans in der Kopf-Hals-Region. Eine retrospektive Studie an 118 Patienten der Fachklinik Hornheide. Medical dissertation, University of Münster; 2002. 
• 16 Schwipper V, Tilkorn H, Sander U. Mißerfolgsraten und Fehlindikationen in der kraniofazialen Epithetik – klinische Daten von 124 Patienten und Literaturübersicht. In: Schwipper V, Tilkorn H, eds. Fortschritte in der kraniofazialen chirurgischen Prothetik und Epithetik. Reinbek, Germany: Einhorn Presse; 1997: 110-152
• 17 Drake L A, Ceilley R I, Cornelison R L The American Academy of Dermatology Committee on Guidelines of Care et al. Guidelines of care for basal cell carcinoma.  J Am Acad Dermatol. 1992;  26 117-120
• 18 Telfer N R, Colver G B, Bowers P W. British Association of Dermatologists . Guidelines for the management of basal cell carcinoma.  Br J Dermatol. 1999;  141 415-423
• 19 Kuijpers D I, Thissen M R, Neumann M H. Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy.  Am J Clin Dermatol. 2002;  3 247-259
• 20 Hauschild A, Breuninger H, Kaufmann R et al.. Short German guidelines: Basal cell carcinoma.  Journal der Deutschen Dermatologischen Gesellschaft. 2008;  6 S2-S4